Erythropoietin drugs are also known as hematopoietin. It is a glycoprotein hormone that controls erythropoiesis or production of RBC. They are used in treatment of different diseases like cancer, chronic renal diseases,
Global erythropoietin drug market is segmented on the basis of type of product into biosimilars, first generation formulation and second generation formulation. On the basis of application market is segmented as oncology, renal diseases, HIV and other and on the basis of end user they are segmented into hospital and pharmacy.
The global Erythropoietin Drug market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Erythropoietin Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Erythropoietin Drug market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Amgen
Johnson & Johnson
Roche
Galenica
Emcure
Kyowa Hakko Kirin
3SBio
Biocon
LG Life Sciences
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Epoetin-alfa
Darbepoetin-alfa
Epoetin-beta
Others
Segment by Application
Anemia
Kidney Disorders
Other
Table of Contents
Executive Summary
1 Erythropoietin Drug Market Overview
1.1 Product Overview and Scope of Erythropoietin Drug
1.2 Erythropoietin Drug Segment by Type
1.2.1 Global Erythropoietin Drug Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Epoetin-alfa
1.2.3 Darbepoetin-alfa
1.2.4 Epoetin-beta
1.2.5 Others
1.3 Erythropoietin Drug Segment by Application
1.3.1 Erythropoietin Drug Consumption Comparison by Application (2014-2025)
1.3.2 Anemia
1.3.3 Kidney Disorders
1.3.4 Other
1.4 Global Erythropoietin Drug Market by Region
1.4.1 Global Erythropoietin Drug Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Erythropoietin Drug Market Size
1.5.1 Global Erythropoietin Drug Revenue (2014-2025)
1.5.2 Global Erythropoietin Drug Production (2014-2025)
2 Global Erythropoietin Drug Market Competition by Manufacturers
2.1 Global Erythropoietin Drug Production Market Share by Manufacturers (2014-2019)
2.2 Global Erythropoietin Drug Revenue Share by Manufacturers (2014-2019)
2.3 Global Erythropoietin Drug Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Erythropoietin Drug Production Sites, Area Served, Product Types
2.5 Erythropoietin Drug Market Competitive Situation and Trends
2.5.1 Erythropoietin Drug Market Concentration Rate
2.5.2 Erythropoietin Drug Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Erythropoietin Drug Production Market Share by Regions
3.1 Global Erythropoietin Drug Production Market Share by Regions
3.2 Global Erythropoietin Drug Revenue Market Share by Regions (2014-2019)
3.3 Global Erythropoietin Drug Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Erythropoietin Drug Production
3.4.1 North America Erythropoietin Drug Production Growth Rate (2014-2019)
3.4.2 North America Erythropoietin Drug Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Erythropoietin Drug Production
3.5.1 Europe Erythropoietin Drug Production Growth Rate (2014-2019)
3.5.2 Europe Erythropoietin Drug Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China Erythropoietin Drug Production (2014-2019)
3.6.1 China Erythropoietin Drug Production Growth Rate (2014-2019)
3.6.2 China Erythropoietin Drug Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan Erythropoietin Drug Production (2014-2019)
3.7.1 Japan Erythropoietin Drug Production Growth Rate (2014-2019)
3.7.2 Japan Erythropoietin Drug Production, Revenue, Price and Gross Margin (2014-2019)
4 Global Erythropoietin Drug Consumption by Regions
4.1 Global Erythropoietin Drug Consumption by Regions
4.2 North America Erythropoietin Drug Consumption (2014-2019)
4.3 Europe Erythropoietin Drug Consumption (2014-2019)
4.4 China Erythropoietin Drug Consumption (2014-2019)
4.5 Japan Erythropoietin Drug Consumption (2014-2019)
5 Global Erythropoietin Drug Production, Revenue, Price Trend by Type
5.1 Global Erythropoietin Drug Production Market Share by Type (2014-2019)
5.2 Global Erythropoietin Drug Revenue Market Share by Type (2014-2019)
5.3 Global Erythropoietin Drug Price by Type (2014-2019)
5.4 Global Erythropoietin Drug Production Growth by Type (2014-2019)
6 Global Erythropoietin Drug Market Analysis by Applications
6.1 Global Erythropoietin Drug Consumption Market Share by Application (2014-2019)
6.2 Global Erythropoietin Drug Consumption Growth Rate by Application (2014-2019)
7 Company Profiles and Key Figures in Erythropoietin Drug Business
7.1 Amgen
7.1.1 Amgen Erythropoietin Drug Production Sites and Area Served
7.1.2 Erythropoietin Drug Product Introduction, Application and Specification
7.1.3 Amgen Erythropoietin Drug Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Erythropoietin Drug Production Sites and Area Served
7.2.2 Erythropoietin Drug Product Introduction, Application and Specification
7.2.3 Johnson & Johnson Erythropoietin Drug Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 Roche
7.3.1 Roche Erythropoietin Drug Production Sites and Area Served
7.3.2 Erythropoietin Drug Product Introduction, Application and Specification
7.3.3 Roche Erythropoietin Drug Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served
7.4 Galenica
7.4.1 Galenica Erythropoietin Drug Production Sites and Area Served
7.4.2 Erythropoietin Drug Product Introduction, Application and Specification
7.4.3 Galenica Erythropoietin Drug Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.5 Emcure
7.5.1 Emcure Erythropoietin Drug Production Sites and Area Served
7.5.2 Erythropoietin Drug Product Introduction, Application and Specification
7.5.3 Emcure Erythropoietin Drug Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business and Markets Served
7.6 Kyowa Hakko Kirin
7.6.1 Kyowa Hakko Kirin Erythropoietin Drug Production Sites and Area Served
7.6.2 Erythropoietin Drug Product Introduction, Application and Specification
7.6.3 Kyowa Hakko Kirin Erythropoietin Drug Production, Revenue, Price and Gross Margin (2014-2019)
7.6.4 Main Business and Markets Served
7.7 3SBio
7.7.1 3SBio Erythropoietin Drug Production Sites and Area Served
7.7.2 Erythropoietin Drug Product Introduction, Application and Specification
7.7.3 3SBio Erythropoietin Drug Production, Revenue, Price and Gross Margin (2014-2019)
7.7.4 Main Business and Markets Served
7.8 Biocon
7.8.1 Biocon Erythropoietin Drug Production Sites and Area Served
7.8.2 Erythropoietin Drug Product Introduction, Application and Specification
7.8.3 Biocon Erythropoietin Drug Production, Revenue, Price and Gross Margin (2014-2019)
7.8.4 Main Business and Markets Served
7.9 LG Life Sciences
7.9.1 LG Life Sciences Erythropoietin Drug Production Sites and Area Served
7.9.2 Erythropoietin Drug Product Introduction, Application and Specification
7.9.3 LG Life Sciences Erythropoietin Drug Production, Revenue, Price and Gross Margin (2014-2019)
7.9.4 Main Business and Markets Served
8 Erythropoietin Drug Manufacturing Cost Analysis
8.1 Erythropoietin Drug Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Erythropoietin Drug
8.4 Erythropoietin Drug Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 Erythropoietin Drug Distributors List
9.3 Erythropoietin Drug Customers
10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors
11 Global Erythropoietin Drug Market Forecast
11.1 Global Erythropoietin Drug Production, Revenue Forecast
11.1.1 Global Erythropoietin Drug Production Growth Rate Forecast (2019-2025)
11.1.2 Global Erythropoietin Drug Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global Erythropoietin Drug Price and Trend Forecast (2019-2025)
11.2 Global Erythropoietin Drug Production Forecast by Regions (2019-2025)
11.2.1 North America Erythropoietin Drug Production, Revenue Forecast (2019-2025)
11.2.2 Europe Erythropoietin Drug Production, Revenue Forecast (2019-2025)
11.2.3 China Erythropoietin Drug Production, Revenue Forecast (2019-2025)
11.2.4 Japan Erythropoietin Drug Production, Revenue Forecast (2019-2025)
11.3 Global Erythropoietin Drug Consumption Forecast by Regions (2019-2025)
11.3.1 North America Erythropoietin Drug Consumption Forecast (2019-2025)
11.3.2 Europe Erythropoietin Drug Consumption Forecast (2019-2025)
11.3.3 China Erythropoietin Drug Consumption Forecast (2019-2025)
11.3.4 Japan Erythropoietin Drug Consumption Forecast (2019-2025)
11.4 Global Erythropoietin Drug Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global Erythropoietin Drug Consumption Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
